Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography.

Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. Abstract Text:

    bassam m tashtoushBassam M Tashtoush,jaber qasemJaber Qasem,joshua d williamsJoshua D Williams,tad p dewaldTad P DeWald,elaine l jacobsonElaine L Jacobson,myron k jacobsonMyron K Jacobson,

    Myristyl nicotinate is an ester prodrug under development for delivery of nicotinic acid to skin for treatment and prevention of conditions that involve skin barrier impairment such as chronic photodamage and atopic dermatitis or for mitigating skin barrier impairment that results from therapy such as retinoids or steroids. The formulation stability of myristyl nicotinate is crucial because even small amounts of free nicotinic acid cause skin flushing, an effect that is not harmful but would severely limit tolerability. We report here reversed-phase HPLC methods for the rapid analysis of myristyl nicotinate and nicotinic acid in dermatological preparations. Because of the large differences in polarity, myristyl nicotinate and nicotinic acid were analyzed by different chromatographic conditions, but they can be rapidly extracted from cream formulations using HPLC mobile phase as a solvent followed by HPLC analysis in less than 10 min. The methods were validated in terms of linearity, precision and accuracy and mean recovery of myristyl nicotinate from topical creams ranged from 97.0-101.2%. Nicotinic acid at levels of 0.01% in the formulations could be quantified. Stability studies show that myristyl nicotinate formulations are stable at room temperature for 3 years with less than 0.05% conversion to nicotinic acid. These methods will be effective for routine analysis of myristyl nicotinate stability in dermatological formulations.

    Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. Publishing Authors By Initials

    bm tashtoushBM Tashtoush,j qasemJ Qasem,jd williamsJD Williams,tp dewaldTP DeWald,el jacobsonEL Jacobson,mk jacobsonMK Jacobson,

    For similar investigative techniques: chemistry, analytical: photometry: spectrophotometry: spectrophotometry, ultraviolet research abstracts see: investigative techniques: chemistry, analytical: photometry: spectrophotometry: spectrophotometry, ultraviolet research

    PUBMED ID PMID:

    MEDLINE DATE:

    Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of pharmaceutical and biomedical analysis

    VOLUME: 43

    Page Numbers: 893-9

    Journal Abbreviation:

    ISSN: 0731-7085

    DAY: 16

    MONTH: 10

    YEAR: 2006

    Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8309336

    Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. Keywords Mesh Terms:

    KEYWORDS: Spectrophotometry, Ultraviolet

    MESH TERMS: analysis

    Chemical & Substance for Abstract: Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. Information

    Substance Name: Niacin

    Registry Number: 59-67-6

    Grant and Affiliation Information for Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography.

    AFFILIATION: Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: R44 CA-90084

    ACRONYM: CA

    MEDLINETA: J Pharm Biomed Anal

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News